Yoshihiro Uesawa (Y Uesawa)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 53

Top Topics

Molecular Docking

Squamous Cell Carcinoma

Clostridium Difficile

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

Medicines (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ryuichiro Hosoya, Reiko Ishii-Nozawa, Tomoko Terajima, Hajime Kagaya, Yoshihiro Uesawa
The Association between Molecular Initiating Events and Drug-Induced Hiccups. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Moena Kagaya, Yoshihiro Uesawa
Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Mami Kikegawa, Hideko Sone, Yoshihiro Uesawa
Comprehensive Analysis of Drug-Induced Parkinson-like Events. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Ryuichiro Hosoya, Reiko Ishii-Nozawa, Tomoko Terajima, Hajime Kagaya, Yoshihiro Uesawa
The Association between Molecular Initiating Events and Drug-Induced Hiccups. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yoshihiro Uesawa
Progress in Predicting Ames Test Outcomes from Chemical Structures: An In-Depth Re-Evaluation of Models from the 1st and 2nd Ames/QSAR International Challenge Projects. International journal of molecular sciences 25 (3) (2024)
Moena Kagaya, Yoshihiro Uesawa
Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Yoshihiro Uesawa
Progress in Predicting Ames Test Outcomes from Chemical Structures: An In-Depth Re-Evaluation of Models from the 1st and 2nd Ames/QSAR International Challenge Projects. International journal of molecular sciences 25 (3) (2024)
Mami Kikegawa, Hideko Sone, Yoshihiro Uesawa
Comprehensive Analysis of Drug-Induced Parkinson-like Events. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Ryuichiro Hosoya, Reiko Ishii-Nozawa, Tomoko Terajima, Hajime Kagaya, Yoshihiro Uesawa
The Association between Molecular Initiating Events and Drug-Induced Hiccups. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yoshihiro Uesawa
Progress in Predicting Ames Test Outcomes from Chemical Structures: An In-Depth Re-Evaluation of Models from the 1st and 2nd Ames/QSAR International Challenge Projects. International journal of molecular sciences 25 (3) (2024)
Yoshihiro Uesawa
Efficiency of pharmaceutical toxicity prediction in computational toxicology. Toxicological research 40 (1) (2024)
Yoshihiro Uesawa
Efficiency of pharmaceutical toxicity prediction in computational toxicology. Toxicological research 40 (1) (2024)
Yoshihiro Uesawa
Progress in Predicting Ames Test Outcomes from Chemical Structures: An In-Depth Re-Evaluation of Models from the 1st and 2nd Ames/QSAR International Challenge Projects. International journal of molecular sciences 25 (3) (2024)
Yuriko Nakao, Mizuho Asada, Yoshihiro Uesawa
Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Ayako Furuhama, A Kitazawa, J Yao, Carlos E Matos Dos Santos, James F Rathman, Chihae Yang, J V Ribeiro, Kevin P Cross, G Myatt, G Raitano, Emilio Benfenati, Nina Jeliazkova, R Saiakhov, Suman K Chakravarti, Robert Foster, C Bossa, C Laura Battistelli, R Benigni, T Sawada, H Wasada, T Hashimoto, M Wu, R Barzilay, Pankaj R Daga, Robert D Clark, Jordi Mestres, A Montero, E Gregori-Puigjané, P Petkov, H Ivanova, O Mekenyan, Slade Matthews, Davy Guan, J Spicer, Raymond Lui, Yoshihiro Uesawa, K Kurosaki, Y Matsuzaka, S Sasaki, Mark T D Cronin, Samuel J Belfield, James W Firman, Nicoleta Spinu, M Qiu, J M Keca, Giuseppina Gini, T Li, W Tong, Huixiao Hong, Z Liu, Y Igarashi, H Yamada, K-I Sugiyama, M Honma
Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project. SAR and QSAR in environmental research 34 (12) (2023)
Yasunari Matsuzaka, Yoshihiro Uesawa
Ensemble Learning, Deep Learning-Based and Molecular Descriptor-Based Quantitative Structure-Activity Relationships. Molecules (Basel, Switzerland) 28 (5) (2023)
Tomoyuki Abe, Hiroshi Sakagami, Shigeru Amano, Shin Uota, Kenjiro Bandow, Yoshihiro Uesawa, Shiori U, Hiroki Shibata, Yuri Takemura, Yu Kimura, Koichi Takao, Yoshiaki Sugita, Akira Sato, Sei-Ichi Tanuma, Hiroshi Takeshima
A Comparative Study of Tumor-Specificity and Neurotoxicity between 3-Styrylchromones and Anti-Cancer Drugs. Medicines (Basel, Switzerland) 10 (7) (2023)
Hideaki Mamada, Mari Takahashi, Mizuki Ogino, Yukihiro Nomura, Yoshihiro Uesawa
Predictive Models Based on Molecular Images and Molecular Descriptors for Drug Screening. ACS omega 8 (40) (2023)
Yasunari Matsuzaka, Yoshihiro Uesawa
Ensemble Learning, Deep Learning-Based and Molecular Descriptor-Based Quantitative Structure-Activity Relationships. Molecules (Basel, Switzerland) 28 (5) (2023)
Shinya Toriumi, Ryuji Mimori, Haruhiko Sakamoto, Hitoshi Sueki, Munehiro Yamamoto, Yoshihiro Uesawa
Examination of Risk Factors and Expression Patterns of Atypical Femoral Fractures Using the Japanese Adverse Drug Event Report Database: A Retrospective Pharmacovigilance Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Risako Hirai, Yoshihiro Uesawa
Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Shinya Toriumi, Ryuji Mimori, Haruhiko Sakamoto, Hitoshi Sueki, Munehiro Yamamoto, Yoshihiro Uesawa
Examination of Risk Factors and Expression Patterns of Atypical Femoral Fractures Using the Japanese Adverse Drug Event Report Database: A Retrospective Pharmacovigilance Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Yasunari Matsuzaka, Yoshihiro Uesawa
Ensemble Learning, Deep Learning-Based and Molecular Descriptor-Based Quantitative Structure-Activity Relationships. Molecules (Basel, Switzerland) 28 (5) (2023)
Ayano Kawabe, Yoshihiro Uesawa
Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Kyosuke Kimura, Mami Kikegawa, Yusuke Kan, Yoshihiro Uesawa
Identifying Crude Drugs in Kampo Medicines Associated with Drug-Induced Liver Injury Using the Japanese Adverse Drug Event Report Database: A Comprehensive Survey. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Shinya Toriumi, Ryuji Mimori, Haruhiko Sakamoto, Hitoshi Sueki, Munehiro Yamamoto, Yoshihiro Uesawa
Examination of Risk Factors and Expression Patterns of Atypical Femoral Fractures Using the Japanese Adverse Drug Event Report Database: A Retrospective Pharmacovigilance Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Shinya Toriumi, Ryuji Mimori, Haruhiko Sakamoto, Hitoshi Sueki, Munehiro Yamamoto, Yoshihiro Uesawa
Examination of Risk Factors and Expression Patterns of Atypical Femoral Fractures Using the Japanese Adverse Drug Event Report Database: A Retrospective Pharmacovigilance Study. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Kousuke Nishikiori, Kentaro Tanaka, Yoshihiro Uesawa
Construction of a prediction model for drug removal rate in hemodialysis based on chemical structures. Molecular diversity 26 (5) (2022)
Yusuke Kan, Mizuho Asada, Yoshihiro Uesawa
Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study. PloS one 17 (8) (2022)
Yasunari Matsuzaka, Yoshihiro Uesawa
A Deep Learning-Based Quantitative Structure-Activity Relationship System Construct Prediction Model of Agonist and Antagonist with High Performance. International journal of molecular sciences 23 (4) (2022)
Hideaki Mamada, Yukihiro Nomura, Yoshihiro Uesawa
Novel QSAR Approach for a Regression Model of Clearance That Combines DeepSnap-Deep Learning and Conventional Machine Learning. ACS omega 7 (20) (2022)
Kotone Naitoh, Yuta Orihara, Hiroshi Sakagami, Takumi Miura, Keitaro Satoh, Shigeru Amano, Kenjiro Bandow, Yosuke Iijima, Kota Kurosaki, Yoshihiro Uesawa, Masashi Hashimoto, Hidetsugu Wakabayashi
Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives. International journal of molecular sciences 23 (5) (2022)
Kenta Yamaoka, Masaki Fujiwara, Mayako Uchida, Yoshihiro Uesawa, Nobuyuki Muroi, Tadashi Shimizu
Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset. Life (Basel, Switzerland) 12 (9) (2022)
Mashiro Okunaka, Daisuke Kano, Yoshihiro Uesawa
Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea. International journal of molecular sciences 23 (20) (2022)
Aruna Chhikara, Praveen K Roayapalley, Hiroshi Sakagami, Shigeru Amano, Keitaro Satoh, Yoshihiro Uesawa, Umashankar Das, Swagatika Das, Edgar A Borrego, Cristina D Guerena, Clare R Hernandez, Renato J Aguilera, Jonathan R Dimmock
Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity. Molecules (Basel, Switzerland) 27 (19) (2022)
Ryuichiro Hosoya, Reiko Ishii-Nozawa, Kota Kurosaki, Yoshihiro Uesawa
Analysis of Factors Associated with Hiccups Using the FAERS Database. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Hayato Akimoto, Yoshihiro Uesawa, Shigeru Hishinuma
Molecular Determinants of the Kinetic Binding Properties of Antihistamines at the Histamine H1 Receptors. International journal of molecular sciences 22 (5) (2021)
Mashiro Okunaka, Daisuke Kano, Reiko Matsui, Toshikatsu Kawasaki, Yoshihiro Uesawa
Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Kota Kurosaki, Yoshihiro Uesawa
Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions. Biomolecules 11 (7) (2021)
Hideaki Mamada, Yukihiro Nomura, Yoshihiro Uesawa
Prediction Model of Clearance by a Novel Quantitative Structure-Activity Relationship Approach, Combination DeepSnap-Deep Learning and Conventional Machine Learning. ACS omega 6 (36) (2021)
Shinya Toriumi, Akinobu Kobayashi, Hitoshi Sueki, Munehiro Yamamoto, Yoshihiro Uesawa
Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Yasunari Matsuzaka, Shin Totoki, Kentaro Handa, Tetsuyoshi Shiota, Kota Kurosaki, Yoshihiro Uesawa
Prediction Models for Agonists and Antagonists of Molecular Initiation Events for Toxicity Pathways Using an Improved Deep-Learning-Based Quantitative Structure-Activity Relationship System. International journal of molecular sciences 22 (19) (2021)
Mashiro Okunaka, Daisuke Kano, Reiko Matsui, Toshikatsu Kawasaki, Yoshihiro Uesawa
Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Hideaki Mamada, Kazuhiko Iwamoto, Yukihiro Nomura, Yoshihiro Uesawa
Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans. Molecular diversity 25 (3) (2021)
Kota Kurosaki, Raymond Wu, Yoshihiro Uesawa
A Toxicity Prediction Tool for Potential Agonist/Antagonist Activities in Molecular Initiating Events Based on Chemical Structures. International journal of molecular sciences 21 (21) (2020)
Yoshiaki Sugita, Koichi Takao, Yoshihiro Uesawa, Junko Nagai, Yosuke Iijima, Motohiko Sano, Hiroshi Sakagami
Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma. Medicines (Basel, Switzerland) 7 (9) (2020)
Yasunari Matsuzaka, Yoshihiro Uesawa
Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library. Molecules (Basel, Switzerland) 25 (12) (2020)
Shinya Toriumi, Akinobu Kobayashi, Yoshihiro Uesawa
Comprehensive Study of the Risk Factors for Medication-Related Osteonecrosis of the Jaw Based on the Japanese Adverse Drug Event Report Database. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)
Yasunari Matsuzaka, Yoshihiro Uesawa
Prediction Model with High-Performance Constitutive Androstane Receptor (CAR) Using DeepSnap-Deep Learning Approach from the Tox21 10K Compound Library. International journal of molecular sciences 20 (19) (2019)
Junko Nagai, Mai Imamura, Hiroshi Sakagami, Yoshihiro Uesawa
QSAR Prediction Model to Search for Compounds with Selective Cytotoxicity Against Oral Cell Cancer. Medicines (Basel, Switzerland) 6 (2) (2019)
Yoshihiro Uesawa, Naotaka Tsuji
Bananas decrease acetaminophen potency in in vitro assays. PloS one 13 (10) (2018)
Hiroshi Sakagami, Taihei Watanabe, Tomonori Hoshino, Naoto Suda, Kazumasa Mori, Toshikazu Yasui, Naoki Yamauchi, Harutsugu Kashiwagi, Tsuneaki Gomi, Takaaki Oizumi, Junko Nagai, Yoshihiro Uesawa, Koichi Takao, Yoshiaki Sugita
Recent Progress of Basic Studies of Natural Products and Their Dental Application. Medicines (Basel, Switzerland) 6 (1) (2018)
Ryuichiro Hosoya, Yoshihiro Uesawa, Reiko Ishii-Nozawa, Hajime Kagaya
Analysis of factors associated with hiccups based on the Japanese Adverse Drug Event Report database. PloS one 12 (2) (2017)